Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: A double-blind, randomized controlled trial

Clinical Infectious Diseases

Volumn 54, Issue 9, 2012, Pages 1304-1313

  Aurelius, E ^a   Franzen Rohl E ^a   Glimker, M ^a   Akre, O ^a   Grillner, L ^b   Jorup Ronstrom C ^a   Studahl, M ^c  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; VALACICLOVIR;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART PALPITATION; HERPES SIMPLEX VIRUS 2; HUMAN; LOOSE FECES; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; NEUROLOGICAL COMPLICATION; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENT DISEASE; SIDE EFFECT; SWEATING; VIRUS MENINGITIS;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; MALE; MENINGITIS, VIRAL; PROSPECTIVE STUDIES; RECURRENCE; SWEDEN; TREATMENT OUTCOME; VALINE;

EID: 84859771338     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis031     Document Type: Article

References (32)

1. Jonsson MK, Levi M, Rudén U, Wahren B. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study. Scand J Infect Dis 2006; 38:357-65. (Pubitemid 43832402)
2. Berntsson M, Tunbäck P, Ellström A, Krantz I, Löwhagen GB. Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden. Acta Derm Venereol 2009; 89:623-6.
3. Sköldenberg B, Jeansson S, Wolontis S. Herpes simplex virus type 2 and acute aseptic meningitis. Clinical features of cases with isolation of herpes simplex virus from cerebrospinal fluids. Scand J Infect Dis 1975; 7:227-32.
4. Corey L, Adams HG, Brown ZA, Holmes KK. Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med 1983; 98:958-72. (Pubitemid 13053413)
5. Sasadeusz JJ, Sacks SL. Herpes latency, meningitis, radiculomyelopathy and disseminated infection. Genitourin Med 1994; 70:369-77.
6. Schlesinger Y, Tebas P, Gaudreault-Keener M, Buller RS, Storch GA. Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction. Clin Infect Dis 1995; 20:842-8.
7. Kupila L, Vuorinen T, Vainionpää R, Hukkanen V, Marttila RJ, Kotilainen P. Etiology of aspetic meningitis and encephalitis in an adult population. Neurology 2006; 66:75-80. (Pubitemid 43739596)
8. Franzen-Röhl E, Larsson K, Skoog E, et al. High diagnostic yield by CSF-PCR for entero-and herpes simplex viruses and TBEV serology in adults with acute aseptic meningitis in Stockholm. Scand J Infect Dis 2008; 40:914-21.
9. Bergström T, Vahlne A, Alestig K, Jeansson S, Forsgren M, Lycke E. Primary and recurrent herpes simplex virus type 2-induced meningitis. J Infect Dis 1990; 162:322-30. (Pubitemid 20239943)
10. Aurelius E, Forsgren M, Gille E, Sköldenberg B. Neurologic morbidity after herpes simplex virus type 2 meningitis: a retrospective study of 40 patients. Scand J Infect Dis 2002; 34:278-83. (Pubitemid 34520672)
11. Tedder DG, Ashley R, Tyler KL, Levin MJ. Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med 1994; 121:334-8.
12. Kallio-Laine K, Seppänen M, Kautiainen H, et al. Recurrent lymphocytic meningitis positive for herpes simplex virus type 2. Emerg Infect Dis 2009; 15:1119-22.
13. Martinez V, Caumes E, Chosidow O. Treatment to prevent recurrent genital herpes. Curr Opin Infect Dis 2008; 21:42-8.
14. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. J Infect Dis 1998; 178:603-10. (Pubitemid 28397205)
15. Bergström T, Alestig K. Treatment of primary and recurrent herpes simplex virus type 2 induced meningitis with acyclovir. Scand J Infect Dis 1990; 22:239-40. (Pubitemid 20169940)
16. Berger JR. Benign aseptic (Mollaret's) meningitis after genitalis herpes. Lancet 1991; 337:1360-1.
17. Aurelius E, Johansson B, Sköldenberg B, Staland A, Forsgren M. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991; 337:189-92.
18. Aurelius E, Johansson B, Sköldenberg B, Forsgren M. Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid. J Med Virol 1993; 39:179-86. (Pubitemid 23085127)
19. Schmutzhard J, Merete Riedel H, Zweygberg Wirgart B, Grillner L. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation. J Clin Virol 2004; 29:120-6. (Pubitemid 38121583)
20. Franzen-Röhl E, Tiveljung-Lindell A, Grillner L, Aurelius E. Increased detection rate in diagnosis of herpes simplex virus type 2 meningitis by real-time PCR using cerebrospinal fluid samples. J Clin Microbiol 2007; 45:2516-20. (Pubitemid 47295482)
21. Namvar L, Olofsson S, Bergström T, Lindh M. Detection and typing of herpes simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol 2005; 43:2058-64. (Pubitemid 40656208)
22. Svennerholm B, Olofsson S, Jeansson S, Vahlne A, Lycke E. Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol 1984; 19:235-9. (Pubitemid 14185624)
23. Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis 2003; 30:310-4. (Pubitemid 36397831)
24. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:61-3.
25. Leung DT, Sacks SL. Current recommendations for the treatment of genital herpes. Drugs 2000; 60:1329-52. (Pubitemid 32039390)
26. Lycke J, Malmeström C, Sta°hle L. Acyclovir levels in serum and cerebrospinal fluid after oral administration of valacyclovir. Antimicrob Agents Chemother 2003; 47:2438-41. (Pubitemid 36919441)
27. Read SJ, Kurtz JB. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol 1999; 37:1352-5. (Pubitemid 29187798)
28. Johnston C, Magaret A, Selke S, Remington M, Corey L, Wald A. Herpes simplex viremia during primary genital infection. J Infect Dis 2008; 198:31-4. (Pubitemid 351920286)
29. Franzen-Röhl E, Schepis D, Lagrelius M, et al. Increased cell-mediated immune responses in patients with recurrent herpes simplex virus type 2 meningitis. Clin Vaccine Immunol 2001; 18:655-60.
30. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999; 341: 1432-8. (Pubitemid 29513459)
31. Aurelius E. Neurological disease in herpes simplex virus type 2 meningitis (HSV-2) infection. In: Studahl M, Cinque P, Bergström T, eds. Herpes simplex viruses. New York, NY: Taylor and Francis, 2006:317-32.
32. Wald A, Zeh J, Selke S, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 2000; 342:844-50. (Pubitemid 30165207)